发明名称 POLYMORPHIC FORM OF PRIDOPIDINE HYDROCHLORIDE
摘要 This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.
申请公布号 EA023462(B1) 申请公布日期 2016.06.30
申请号 EA20140090569 申请日期 2012.09.06
申请人 TEVA PHARMACEUTICALS INTERNATIONAL GMBH 发明人 SONESSON CLAS;PITTELKOW THOMAS;FROESTRUP BRIAN;ZIMMERMANN ANNE
分类号 C07D211/24;A61K31/445;A61P25/28 主分类号 C07D211/24
代理机构 代理人
主权项
地址